GPI+VIM双靶点脑深部电刺激治疗药物难治性震颤的帕金森病患者
该回顾性研究纳入2015至2020年接受同期GPI+VIM DBS手术的13例帕金森病患者(11例单侧,2例双侧),评估双靶点刺激对药物难治性震颤的疗效。结果显示双靶点刺激平均减少90.6%的震颤评分,而单独GPI刺激仅减少21.8%,15个大脑半球中13个需要VIM刺激才能实现优秀震颤控制。
要点
- GPI+VIM双靶点刺激对药物难治性震颤有效,平均减少90.6%震颤评分
- 单独GPI刺激震颤减少仅21.8%,多数半球需追加VIM刺激
- 对于适合GPI靶点但药物难治性震颤的患者,双靶点刺激是有效选择
核心结论
- GPI+VIM双靶点刺激对药物难治性震颤有效,13例中11例需双靶点才能充分控制震颤
- 对于症状和合并症适合GPI靶点且药物难治性震颤的患者,双靶点刺激是有效选择
研究设计与样本
- 回顾性综述,纳入2015至2020年接受同期GPI+VIM DBS手术且有随访数据的帕金森病患者13例
- 11例单侧手术,2例双侧手术,共15个大脑半球
- 术前统一帕金森病评定量表评分在用药和未用药状态下获取,术后GPI电极基线开启,分别在VIM刺激开启和关闭时评分
主要发现
- 双靶点GPI+VIM刺激平均减少90.6%(SD 15.0%)的震颤评分
- 单独GPI刺激平均减少21.8%(SD 71.9%)的震颤评分
- 药物治疗平均减少30.9%(SD 37.8%)的震颤评分
- 僵直和运动迟缓的改善仅通过GPI刺激即可实现
- 15个大脑半球中13个需要VIM刺激才能达到优秀震颤控制,仅2例患者无需VIM刺激
临床怎么用
- 对于适合GPI靶点但存在药物难治性震颤的帕金森病患者,可考虑同期GPI+VIM双靶点DBS
- 术后可通过分别开启和关闭VIM刺激来评估震颤控制效果
局限性
- 回顾性研究,样本量小(13例患者,15个半球)
- 仅纳入有随访数据的患者,可能存在选择偏倚
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Randomized controlled trials have demonstrated that deep brain stimulation (DBS) of both the globus pallidus internus (GPI) and subthalamic nucleus (STN) for Parkinson's disease (PD) is superior to the best medical therapy. Tremor is particularly responsive to DBS, with reports of 70%-80% improvement. However, a small number of patients do not obtain the expected response with both STN and GPI targets. Indeed, the authors' patient population had a similar 81.2% tremor reduction with a 9.6% failure rate. In an analysis of these failures, they identified patients with preoperative on-medication tremor who subsequently received a GPI lead as a subpopulation at higher risk for inadequate tremor control. Thereafter, STN DBS was recommended for patients with on-medication tremor. However, for the patients with symptoms and comorbidities that favored GPI as the target, dual GPI and ventral intermediate nucleus of the thalamus (VIM) leads were proposed. This report details outcomes for those patients. METHODS: This is a retrospective review of patients with PD who met the criteria for and underwent simultaneous GPI+VIM DBS surgery from 2015 to 2020 and had available follow-up data. The preoperative Unified Parkinson's Disease Rating Scale scores were obtained with the study participants on and off their medication. Postoperatively, the GPI lead was kept on at baseline and scores were obtained with and without VIM stimulation. RESULTS: Thirteen PD patients with significant residual preoperative tremor on medication underwent simultaneous GPI+VIM DBS surgery (11 unilateral, 2 bilateral). A mean 90.6% (SD 15.0%) reduction in tremor scores was achieved with dual GPI+VIM stimulation compared to a 21.8% (SD 71.9%) reduction with GPI stimulation alone and a 30.9% (SD 37.8%) reduction with medication. Although rigidity and bradykinesia reductions were accomplished with just GPI stimulation, 13 of the 15 hemispheres required VIM stimulation to achieve excellent tremor control. CONCLUSIONS: GPI+VIM stimulation was required to adequately control tremor in all but 2 patients in this series, substantiating the authors' hypothesis that, in their population, medication-resistant tremor does not completely respond to GPI stimulation. Dual stimulation of the GPI and VIM proved to be an effective option for the patients who had symptoms and comorbidities that favored GPI as a target and had medication-resistant tremor.
引用
- Azghadi A, Rajagopal MM, Atkinson KA, et al. Utility of GPI+VIM dual-lead deep brain stimulation for Parkinson's disease patients with significant residual tremor on medication. J Neurosurg. 2021. PMID: 34598140. doi:10.3171/2021.4.JNS21502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。